Production of reactive oxygen species after reperfusion in vitro and in vivo: Protective effect of nitric oxide

Journal of Neurosurgery

Volumn 93, Issue 1, 2000, Pages 99-107

  Mason, R Bryan ^b   Pluta, Ryszard M ^b   Walbridge, Stuart ^b   Wink, David A ^b   Oldfield, Edward H ^a   Boock, Robert J ^b  

^a Surgical Neurology Branch   (United States)

^b NONE

Author keywords

Anoxia; Nitric oxide; Nitric oxide donor; Oxygen free radical; Reperfusion injury; Stroke

Indexed keywords

DIETHANOLAMINE; NITRIC OXIDE; OXYGEN RADICAL; REACTIVE OXYGEN METABOLITE;

ANOXIA; ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; CELL PROTECTION; CYTOTOXICITY; DRUG EFFECT; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; REOXYGENATION; REPERFUSION INJURY; STROKE;

EID: 0033922123     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2000.93.1.0099     Document Type: Article

References (59)

1. Ashwal S, Cole DJ, Osborne TN, et al: Dual effects of L-NAME during transient focal cerebral ischemia in spontaneously hypertensive rats. Am J Physiol 267:H276-H284, 1994
2. Beckman JS: The double-edged role of nitric oxide in brain function and superoxide-mediated injury. J Dev Physiol 15: 53-59, 1991
3. Buisson A, Plotkine M, Boulu RG: The neuroprotective effect of a nitric oxide inhibitor in a rat model of focal cerebral ischaemia. Br J Pharmacol 106:766-767, 1992
4. Busch E, Krüger K, Allegrini PR, et al: Reperfusion after thrombolytic therapy of embolic stroke in the rat: magnetic resonance and biochemical imaging. J Cereb Blood Flow Metab 18:407-418, 1998
5. Busse R, Lückhoff A, Bassenge E: Endothelium-derived relaxant factor inhibits platelet activation. Naunyn Schmiedebergs Arch Pharmacol 336:566-571, 1987
6. Chiueh CC, Huang SJ, Murphy DL: Enhanced hydroxyl radical generation by 2′-methyl analog of MPTP: suppression by clorgyline and deprenyl. Synapse 11:346-348, 1992
7. Chiueh CC, Krishna G, Tulsi P, et al: Intracranial microdialysis of salicylic acid to detect hydroxyl radical generation through dopamine autooxidation in the caudate nucleus: effects of MPP. Free Radic Biol Med 13:581-583, 1992
8. Christodoulou D, Kudo S, Cook JA, et al: Electrochemical methods for the detection of nitric oxide. Methods Enzymol 268:69-83, 1996
9. Dawson DA, Kusumoto K, Graham DI, et al: Inhibition of nitric oxide synthesis does not reduce infarct volume in a rat model of focal cerebral ischaemia. Neurosci Lett 142:151-154, 1992
10. Dawson VL, Dawson TM, London ED, et al: Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci USA 88:6368-6371, 1991
11. del Zoppo GJ: Thrombolytic therapy in the treatment of stroke. Drugs 54 (Suppl 3):90-99, 1997
12. Flaherty JT, Weisfeldt ML: Reperfusion injury. Free Radic Biol Med 5:409-419, 1988
13. Gerhart DZ, Broderius MA, Drewes LR: Cultured human and canine endothelial cells from brain microvessels. Brain Res Bull 21:785-793, 1988
14. Hallenbeck JM, Dutka AJ: Background review and current concepts of reperfusion injury. Arch Neurol 47:1245-1254, 1990
15. Hara E, Takahashi K, Tominaga T, et al: Expression of heme oxygenase and inducible nitric oxide synthase mRNA in human brain tumors. Biochem Biophys Res Comm 224:153-158, 1996
16. Hoffman J: Thrombolytic therapy of strokes: Part II. Emerg Med Acute Care Essays 20:1-4, 1996
17. Iadecola C, Pelligrino D, Moskowitz MA, et al: Nitric oxide synthase inhibition and cerebrovascular regulation. J Cereb Blood Flow Metab 14:175-192, 1994
18. Iadecola C, Zhang F, Xu S, et al: Inducible nitric oxide synthase gene expression in brain following cerebral ischemia. J Cereb Blood Flow Metab 15:378-384, 1995
19. Iadecola C, Zhang F, Xu X: Role of nitric oxide synthase-containing vascular nerves in cerebrovasodilation elicited from cerebellum. Am J Physiol 264:R738-R746, 1993
20. Ignarro LJ: Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol Toxicol 30:535-560, 1990
21. Isayama K, Pitts LH, Nishimura MC: Evaluation of 2,3,5-triphenyltetrazolium chloride staining to delineate rat brain infarcts. Stroke 22:1394-1398, 1991
22. Keefer LK, Nims RW, Davies KM, et al: "NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms. Methods Enzymol 268: 281-293, 1996
23. Kimura M, Dietrich HH, Dacey RG Jr: Nitric oxide regulates cerebral arteriolar tone in rats. Stroke 25:2227-2234, 1994
24. Kontos HA: Oxygen radicals in cerebral vascular injury. Circ Res 57:508-516, 1985
25. G-nitro-L-arginine delays the development of brain injury during focal ischemia in rats. Stroke 26:282-289, 1995
26. Lefer DJ, Nakanishi K, Johnston WE, et al: Antineutrophil and myocardial protecting actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion in dogs. Circulation 88:2337-2350, 1993
27. Lipton SA, Choi YB, Pan ZH, et al: A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364:626-632, 1993
28. Major EO, Amemiya K, Elder G, et al: Glial cells of the human developing brain and B cells of the immune system share a common DNA binding factor for recognition of the regulatory sequences of the human polyomavirus, JCV. J Neurosci Res 27:461-471, 1990
29. Maragos CM, Morley D, Wink DA: Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects. J Med Chem 34:3242-3247, 1991
30. Moncada S, Radomski MW, Palmer RM: Endothelium-derived relaxing factor: identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem Pharm 37: 2495-2501, 1988
31. Morikawa E, Huang Z, Moskowitz MA: L-Arginine decreases infarct size caused by middle cerebral arterial occlusion in SHR. Am J Physiol 263:H1632-H1635, 1992
32. Nagafuji T, Matsui T, Koide T, et al: Blockade of nitric oxide formation by Nω-nitro-L-arginine mitigates ischemic brain edema and subsequent cerebral infarction in rats. Neurosci Lett 147:159-162, 1992
33. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581-1587, 1995
34. Nims RW, Cook JC, Krishna MC, et al: Colorimetric assays for nitric oxide and nitrogen oxide species formed from various nitric oxide stock solutions and donor compounds. Methods Enzymol 268:93-105, 1996
35. Nishikawa T, Kirsch JR, Koehler RC, et al: Nitric oxide synthase inhibition reduces caudate injury following transient focal ischemia in cats. Stroke 25:877-885, 1994
36. Node K, Kitakaze M, Kosaka H, et al: Amelioration of ischemia- and reperfusion-induced myocardial injury by 17β-estradiol. Role of nitric oxide and calcium-activated potassium channels. Circulation 96:1953-1963, 1997
37. Palmer RMJ, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524-526, 1987
38. Parkins CS, Dennis MF, Stratford MRL, et al: Ischemia reperfusion injury in tumors: the role of oxygen free radicals and nitric oxide. Cancer Res 55:6026-6029, 1995
39. Pluta RM, Oldfield EH, Boock RJ: Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage. J Neurosurg 87:746-751, 1997
40. Prado R, Watson BC, Wester P: Effects of nitric oxide synthase inhibition on cerebral blood flow following bilateral carotid artery occlusion and recirculation in the rat. J Cereb Blood Flow Metab 13:720-723, 1993
41. Pulsinelli WA, Brierley JB: A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke 10:267-272, 1979
42. Rao AK, Pratt C, Berke A, et al: Thrombolysis in myocardial infarction (TIMI) trial - phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Coll Cardiol 11:1-11, 1988
43. Saavedra JE, Southan GJ, Davies KM, et al: Localizing antithrombotic and vasodilatory activity with a novel, ultrafast nitric oxide donor. J Med Chem 39:4361-4365, 1996
44. Sancesario G, Iannone M, Morello M, et al: Nitric oxide inhibition aggravates ischemic damage of hippocampal but not of NADPH neurons in gerbils. Stroke 25:436-444, 1994
45. Silver B, Weber B, Fisher M: Medical therapy for ischemic stroke. Clin Neuropharmacol 19:101-128, 1996
46. Suzuki S, Kassell NF, Lee KS: Hemin activation of an inducible isoform of nitric oxide synthase in vascular smooth-muscle cells. J Neurosurg 83:862-866, 1995
47. Tanaka K, Fukuuchi Y, Gomi S, et al: Inhibition of nitric oxide synthesis impairs autoregulation of local cerebral blood flow in the rat. Neuroreport 4:267-270, 1993
48. The TIMI Study Group: The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings. N Engl J Med 312:932-936, 1985
49. Tomimoto H, Nishimura M, Suenaga T, et al: Distribution of nitric oxide synthase in the human cerebral blood vessels and brain tissue. J Cereb Blood Flow Metab 14:930-938, 1994
50. Wink DA, Hanbauer I, Krishna MC, et al: Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc Natl Acad Sci USA 90:9813-9817, 1993
51. Wink DA, Hanbauer I, Lavai F, et al: Nitric oxide protects against the cytotoxic effects of reactive oxygen species. Ann NY Acad Sci 738:265-278, 1994
52. Wolf PA: An overview of the epidemiology of stroke. Stroke 21 (Suppl 9):II4-II6, 1990
53. Wolozin B, Bacic M, Merrill MJ, et al: Differential expression of carboxyl terminal derivatives of amyloid precursor protein among cell lines. J Neurosci Res 33:163-169, 1992
54. Yamamoto S, Golanov V, Berger SB, et al: Inhibition of nitric oxide synthesis increases focal ischemic infarction in rat. J Cereb Blood Flow Metab 12:717-726, 1992
55. Yoshida T, Limmroth V, Irikura K, et al: The NOS inhibitor, 7-nitroindazole, decreases focal infarct volume but not the response to topical acetylcholine in pial vessels. J Cereb Blood Flow Metab 14:924-929, 1994
56. Zhang F, White JG, Iadecola C: Nitric oxide donors increase blood flow and reduce brain damage in focal ischemia: evidence that nitric oxide is beneficial in the early stages of cerebral ischemia. J Cereb Blood Flow Metab 14:217-226, 1994
57. Zhang F, Xu S, Iadecola C: Time dependence of effect of nitric oxide synthase inhibition on cerebral ischemic damage. J Cereb Blood Flow Metab 15:595-601, 1995
58. Zhang J, Benveniste H, Piantadosi CA: Inhibition of nitric oxide synthase increases extracellular cerebral glutamate concentration after global ischemia. Neurosci Lett 157:179-182, 1993
59. Zhang ZG, Reif D, Macdonald J, et al: ARL 17477, a potent and selective neuronal NOS inhibitor decreases infarct volume after transient middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab 16:599-604, 1996